Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. (SHA: 603392)
China flag China · Delayed Price · Currency is CNY
75.25
+0.47 (0.63%)
Nov 13, 2024, 3:00 PM CST

Beijing Wantai Biological Pharmacy Enterprise Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2014
Period Ending
Sep '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2014
Net Income
-294.041,2484,7362,021677208.86
Upgrade
Depreciation & Amortization
224.21224.21151.9105.2884.4780.51
Upgrade
Other Amortization
31.4131.416.635.032.071.8
Upgrade
Loss (Gain) From Sale of Assets
-0.22-0.22-0.060.72-0.421.37
Upgrade
Asset Writedown & Restructuring Costs
260.46260.462.80.25-0.1
Upgrade
Loss (Gain) From Sale of Investments
-123.56-123.56-46.09-11.25-13.6-13.88
Upgrade
Provision & Write-off of Bad Debts
-23.27-23.2790.6183.9524.074.25
Upgrade
Other Operating Activities
1,048199.37129.6196.8646.9113.41
Upgrade
Change in Accounts Receivable
984.81984.81-1,778-1,707-487.31-81.75
Upgrade
Change in Inventory
-218.34-218.34-296.47-222.97-190.68-49.65
Upgrade
Change in Accounts Payable
-935.62-935.621,1161,322287.39137.31
Upgrade
Change in Other Net Operating Assets
----0--
Upgrade
Operating Cash Flow
844.541,5384,1331,682468.21272.68
Upgrade
Operating Cash Flow Growth
-55.80%-62.79%145.70%259.23%71.71%30.90%
Upgrade
Capital Expenditures
-997.41-1,160-929.91-1,048-390.44-162
Upgrade
Sale of Property, Plant & Equipment
16.580.720.898.192.730.68
Upgrade
Cash Acquisitions
-0.71-0.71----
Upgrade
Investment in Securities
374.44-960.3-2,58914.3986.52-48.2
Upgrade
Other Investing Activities
-781.1466.233.911.115.7811.16
Upgrade
Investing Cash Flow
-1,388-2,054-3,514-1,014-295.4-198.37
Upgrade
Long-Term Debt Issued
-186.44351.6240.3590.37-
Upgrade
Total Debt Issued
110.75186.44351.6240.3590.37-
Upgrade
Long-Term Debt Repaid
--170.57-352.46-92.06-33.77-
Upgrade
Net Debt Issued (Repaid)
-45.1715.87-0.86148.2956.6-
Upgrade
Issuance of Common Stock
54543,46110342.28-
Upgrade
Repurchase of Common Stock
-15.65-15.65-200.17---
Upgrade
Common Dividends Paid
-406.92-907.47-127.49-112.74-1.65-1.04
Upgrade
Other Financing Activities
-173.4-40-5.687.23-17.43-4.13
Upgrade
Financing Cash Flow
-587.14-893.263,12752.79379.79-5.18
Upgrade
Foreign Exchange Rate Adjustments
-5.57.6226.26-8.75-9.010.22
Upgrade
Net Cash Flow
-1,136-1,4023,772711.88543.5969.35
Upgrade
Free Cash Flow
-152.86378.153,203634.1677.77110.68
Upgrade
Free Cash Flow Growth
--88.19%405.03%715.43%-29.73%-
Upgrade
Free Cash Flow Margin
-6.14%6.86%28.63%11.03%3.30%9.35%
Upgrade
Free Cash Flow Per Share
-0.120.302.560.520.070.10
Upgrade
Cash Income Tax Paid
110.74537.31,164295.76145.3499.9
Upgrade
Levered Free Cash Flow
28.8754.721,738-4.04-218.265.28
Upgrade
Unlevered Free Cash Flow
32.259.011,743-0.48-217.1565.93
Upgrade
Change in Net Working Capital
-1,014-110.49776461.51366.22-52.28
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.